Stay updated with breaking news from Legn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Massachusetts Financial Services Co. MA boosted its stake in shares of Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 6.3% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,984,826 shares of the company’s stock after purchasing an additional 117,794 shares during the period. Massachusetts Financial Services […] ....
Legend Biotech Co. (NASDAQ:LEGN – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $45.52 and last traded at $45.75, with a volume of 131838 shares trading hands. The stock had previously closed at $46.19. Analyst Ratings Changes A number of equities […] ....
Scotiabank upgraded shares of Legend Biotech (NASDAQ:LEGN – Free Report) from a sector perform rating to a sector outperform rating in a research note published on Wednesday, MarketBeat reports. The firm currently has $65.00 price target on the stock. A number of other research firms have also issued reports on LEGN. Raymond James assumed coverage […] ....
HC Wainwright restated their buy rating on shares of Legend Biotech (NASDAQ:LEGN – Free Report) in a research report sent to investors on Tuesday, Benzinga reports. HC Wainwright currently has a $87.00 price objective on the stock. HC Wainwright also issued estimates for Legend Biotech’s Q1 2024 earnings at ($0.01) EPS and Q3 2024 earnings […] ....
Legend Biotech Co. (NASDAQ:LEGN – Free Report) – Research analysts at HC Wainwright reduced their Q2 2024 EPS estimates for shares of Legend Biotech in a research note issued to investors on Monday, April 8th. HC Wainwright analyst M. Kapoor now anticipates that the company will post earnings per share of ($0.12) for the quarter, […] ....